CD20 is a CD marker—a molecule on the cell surface ... Diffuse large B cell lymphoma (DLBCL) is cancer involving B cells. Under the microscope, the cells look just like the cancerous T cells ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

Lymphoma, a cancer affecting the immune system ... engineers a patient’s own immune cells to target specific cancer markers, creating a “living drug” that continues working long after ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

“Preliminary data from our Phase 1 APOLLO study showed encouraging safety and efficacy results in lymphoma ... of tumor escape. Since MAR-T cells are not genetically engineered, Marker believes ...

In another aspect, the Hollings team is putting a marker ... for leukemia and lymphoma, but we would like to see this also be used for hard-to-treat cancers," like pancreatic cancer.